Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20
Clinical trial NCT03605238 · WITHDRAWN
Trial details
- NCT number
- NCT03605238
- Sponsor
- Chinese PLA General Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2019-08-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.